期刊文献+

快速检测TOX、CMVIgG抗体的适配子型SPR传感器微阵列的初步构建 被引量:2

Construction of aptamer-based surface plasma resonance biosensor microarray for the rapid detection of toxoplasma godii and cytomegalovirus IgG antibodies
下载PDF
导出
摘要 目的初步构建弓形虫(toxoplasma gondii,TOX)、巨细胞病毒(cytomegalovirus,CMV)IgG抗体的适配子型SPR传感器微阵列的快速检测方法。方法采用SELEX技术筛选TOX、CMV IgG的适配子,并将其整合于SPR生物传感器实时在线分析系统,通过在传感器表面固定探针分子,对溶液中的TOX、CMV IgG进行杂交检测,并进一步研究该检测方法的稳定性与线性检范围。结果该新型快速检测方法能够实现对TOX、CMV IgG的实时检测,检测系统稳定性良好,八通道间检测时互不影响,线性检测范围为20~300μmol/L。结论该实验建立的快速检测方法,具有稳定性好等优点,SPR传感器技术结合适配子技术在临床诊断工作中有着广阔的应用前景。 Objective To construct the aptamer-based surface plasma resonance (SPR) microarray for rapid assay of toxoplasma gondii (TOX) and cytomegalovirus (CMV) IgG antibodies. Methods Aptamers of the TOX gondii and CMV IgG antibodies were screened with the SELEX technique and integrated into the re- al-time online analyzing system on the SPR biosensor. Hybridization of TOX and CMV IgG antibodies in solution was detected according to the probe molecules fixed on the surface of biosensor. The stability and linear detec- tion range of this assay were further investigated. Results The novel rapid method could assay the TOX and CMV IgG antibodies with a good stability and a linear assay range of 20 to 300 i.tmol/L. Conclusion The sta- bility of the rapid assay we established is good. Combined SPR biosensor and aptamer techniques have a broad prospect in clinical assay of TOX and CMV IgG antibody level.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2012年第8期765-767,共3页 Journal of Third Military Medical University
基金 国家自然科学基金(30900348,30927002)~~
关键词 生物芯片 适配子 SPR传感器 biochip aptamer surface plasma resonance biosensor
  • 相关文献

参考文献9

二级参考文献77

共引文献63

同被引文献50

  • 1严馨蕊,高绪文,姚立红,张智清.应用核酸适配子检测细胞因子的新方法-ELONA法[J].生物工程学报,2004,20(5):679-682. 被引量:7
  • 2Ellington A D, Szostak] W, In vitro selection of RNA molecules that bind specific ligands[J]. Nature, 1990, 346: 818-822.
  • 3Tuerk C , Gold L, et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymaerase [J]. Science, 1990, 249 (4968) : 505-510.
  • 4Wang R E, Wu H, Niu Y. Improving the stability of aptamers by chemical modification[J]. Current Medicinal Chemistry, 2011, (27) : 4126-4138.
  • 5Ng E W M, Shima DT , Calias P ,et al. Pegaptanib, a targeted anti- VEGF aptamer for ocular vascular disease. [J] Nat Rev, 2006,5(2) :123-132.
  • 6Ara M N, Hyodo M, Ohga N, et al. Development of a novel DNA aptamer ligand targeting to primary cultured tumor endothelial cells by a cell-based SELEX method [J/OL]. PLoS One. 2012,7 (2) : e50175.
  • 7Dion A Daniels, Hang Chen, Brian J Hicke , et al. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment[J]. Proc Natl Acad Sci USA, 2003 ,100(26): 15416-15421.
  • 8Avci-Adali M, Wilhelm N, Perle N, et al. Absolute quantification of Cell-Bound DNA aptamers during SELEX[J]. Nucleic Acid Therapeutics, 2013, 7 (2) : 125- 130.
  • 9Ashley J, Li SF, et al. Three-dimensional selection of leptin aptamers using capillary electrophoresis and implications for clone validation [J] . Anal Biochem, 2013,434(1):146-152.
  • 10Zhang Li bing, Li Jing, Xu Yuan hong, et al. Solidstate electro chemiluminescence sensor based on the Nafion/poly(sodium4-styrene sulfonate) composite film [J]. Talanta,2009,79:454-459.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部